Department of Audiology Faculty Articles
Evaluating treatments for Ménière's disease: controversies surrounding placebo control.
ISSN
10500545
Publication Date
1-1-2006
Keywords
Double-Blind Method, Ear, Inner, Endolymphatic Sac, Humans, Injections, Intralesional, Meniere Disease, Middle Ear Ventilation, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome, Tympanic Membrane
Abstract
Although double-blind experimental designs are considered the gold standard for documenting treatment effectiveness, many treatments for Ménière's disease have not been evaluated using this methodology. Particularly with a disease characterized by exacerbation and remission, carefully controlled, long-term studies are required. The nature of the placebo effect is described in this article, and the concept of debonafide effect introduced. Ideally, patients should be given treatments supported by evidence-based medicine that have the lowest possible risk of side effects. However, risk minimization may dictate using treatments that have not been proven effective and may evoke debonafide effects.
DOI
https://doi.org/10.3766/jaaa.17.1.4
Volume
17
Issue
1
First Page
27
Last Page
37
Disciplines
Medicine and Health Sciences
NSUWorks Citation
Hamill, Teri A, "Evaluating treatments for Ménière's disease: controversies surrounding placebo control." (2006). Department of Audiology Faculty Articles. 19.
https://nsuworks.nova.edu/hpd_aud_facarticles/19